Category: New research findings

Dr. Steven Greenberg is most likely the most knowledgeable expert in the world concerning cerebral amyloid angiopathy (CAA) and the vascular pathology associated with Alzheimer’s disease. Earlier this week, I had the honor of...

Last week in the New England Journal of Medicine, the results of an interesting proof-of-concept study using focused ultrasound to enhance the ability of the anti-amyloid monoclonal antibody aducanumab to cross the blood blood-brain barrier...

I last posted on my blog three weeks ago.  A few days after that, I came down with what was probably just a bad cold.   It was mainly in my chest with a lot of coughing....

This post originally appeared on my blog in August.  Somehow, I accidently deleted it this week.  Here it is again with my apologies to those who have been unable to find it. If only rebooting my...

My dog Jack and I are diligent about getting our 10,000 steps walking every day.  Many studies have shown that regular exercise reduces the risk of getting dementia including Alzheimer’s, but questions remain: How much...

While doing a genetic genealogical search in 2012, I inadvertently discovered that I have two copies of the APOE-4 allele putting me at very high risk of developing Alzheimer’s dementia. However, as a neurologist,...

Lois, my wife and a retired librarian, got me started keeping track of my book reading using the Goodreads website in 2008. It took me a couple of years to get it right, remembering...

Last February I posted an essay on this blog titled “Hearing loss, aphasia and dementia” about my increasing problem with understanding speech. I suspected that my trouble with speech was due to a combination...

The results of the phase 3 clinical trial of the anti-amyloid monoclonal antibody donanemab were released simultaneously today at the Alzheimer’s Association Clinical Conference (AAIC) in Amsterdam and in a paper published in JAMA....